Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Stabilized estradiol cream composition|
|Abstract:||Loss of potency of estradiol cream compositions found to be due to unexpected oxidation of estradiol. Improved cream composition comprises 1% or less 17.beta.-estradiol in the presence of stabilizing members selected from phenolic-type antioxidants, metal chelating agents, and suspending agents.|
|Inventor(s):||Bequette; Robert J. (Evansville, IN), Hobbs; Linda G. (Evansville, IN), Scott; Joseph A. (Evansville, IN)|
|Assignee:||Mead Johnson & Company (Evansville, IN)|
1. A cream composition for topical estrogen therapy which comprises 17.beta.-estradiol of a concentration of about 1% or less on a weight basis relative to the whole
composition and the remainder being a pharmaceutically acceptable carrier wherein said carrier contains as stabilizers from about 0.01 to about 10% by weight of at least one member selected from
(a) one or more phenolic-type antioxidants selected from the group consisting of t-butylhydroquinone, di-t-amylhydroquinone, di-t-butylhydroquinone, butylhydroxytoluene, butylhydroxyanisole, pyrocatechol, pyrogallol, propyl gallate, and nordihydroguaiaretic acid;
(b) one or more metal chelating agents selected from the group consisting of the sodium edetates (EDTA), and edatic acid; and
(c) one or more suspending agents selected from the group consisting of carbomer, carboxymethylcellulose, hydroxypropyl methylcellulose and methylcellulose.
2. The composition of claim 1 wherein the concentration of antioxidant is less than 0.1% by weight; the metal chelating agent is a sodium edetate which is present in a concentration of less than 0.1% by weight; at least one of the suspending agents is present in a concentration of 1% or less; and 17.beta.-estradiol is present at a 0.1% or less concentration on a weight basis relative to the whole composition.
3. The composition of claim 1 wherein the antioxidant is tertiary butylhydroquinone at a concentration of 0.2 parts per 1,000 parts cream; the metal chelating agent is disodium edetate at a concentration of 0.5 part per 1,000 parts cream; the suspending agent is hydroxypropyl methylcellulose at a concentration of 3 parts per 1,000 parts cream and 17.beta.-estradiol is at the concentration of 0.1 part per 1,000 parts cream.
4. The composition as recited in claim 3 which further comprises per 1,000 parts cream: stearyl alcohol, 70 parts; glyceryl monostearate, 40 parts; white ceresin wax, 70 parts; sodium lauryl sulfate, 3 parts; methylparaben, 1.5 parts; propylene glycol, 100 parts; and purified water, 712 parts.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.